Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis.

AIDS (London, England) - 5 Nov 2004

Panidou Ermioni T, Trikalinos Thomas A, Ioannidis John P A

Abstract excerpt

OBJECTIVE: To estimate the effectiveness of resistance assessments based on viral sequencing (genotypic antiretroviral resistance testing, GART), phenotypic antiretroviral resistance testing (PART) or virtual PART (vPART) in the management of treatment-experienced HIV-1-infected patients. DESIGN:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Infections

Share to Randomized Controlled Trials as Topic

Share to Viral Load

Source

Identifiers

PMID: 15577648
DOI: 10.1097/00002030-200411050-00007

Genes

GART

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15577648-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis.PMID 15577648Read ↗

Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis.Semantic proximity Read ↗

Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study.Semantic proximity Read ↗

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.Semantic proximity Read ↗

Genotypic resistance testing in routine clinical care.Semantic proximity Read ↗

Resistance testing debate: does it make the grade?Semantic proximity Read ↗

A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.Semantic proximity Read ↗

International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations.Semantic proximity Read ↗

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness.Semantic proximity Read ↗

The benefits of HIV resistance testing in optimizing drug discovery.Semantic proximity Read ↗

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.Semantic proximity Read ↗

Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects.Semantic proximity Read ↗

Is resistance testing of benefit in treatment-naive HIV-infected patients?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.